Grassley, Wyden Deliver Opening Remarks in Drug Pricing Hearing - Bloomberg

Go back to Grassley, Wyden Deliver Opening Remarks in Drug Pricing Hearing - Bloomberg

Johnson & Johnson (JNJ) Talc-Related Risk Much Less Than Market Thinks - Cowen

February 28, 2019 12:06 PM EST

Cowen analyst Joshua Jennings weighed in on Johnson & Johnson (NYSE: JNJ) after the company restarted production of cosmetic talk in India after tests find no asbestos.

"We continue to think that the talc-related risk JNJ faces is much less than the market believes,"... More